Annovis Bio, Inc.

ANVS·NYSE·$2.06Share Price as of 11/2·$41MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/15/26 10-KFY 202503/13/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report10/30/26 8-KCurrent report10/20/26 8-KCurrent report08/14/26 8-KCurrent report07/10/26 8-KCurrent report06/17/26

Prospectuses and Registrations

424B5Prospectus supplement05/20/26 424B5Prospectus supplement05/19/26 424B5Prospectus supplement04/09/26 424B5Prospectus supplement10/28/25 424B5Prospectus supplement10/14/25

Proxies

DEFA14AAdditional proxy materials10/07/26 DEF 14ADefinitive proxy09/11/26 PRE 14APreliminary proxy08/25/26 DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26

Ownership

SC 13G/ABeneficial ownership (amended)10/15/26 SC 13GBeneficial ownership08/14/26 SC 13GBeneficial ownership07/29/26 Form 4Insider transaction05/21/26 Form 4Insider transaction04/03/26

Other

UPLOADLetter from the SEC09/30/25 CORRESPCorrespondence with the SEC09/29/25 CORRESPCorrespondence with the SEC09/19/25 UPLOADLetter from the SEC09/04/25 ARSAnnual report to shareholders05/01/25